Table 3.
Neurological symptoms at presentation and during hospital encounter.
| Participants | |
|---|---|
| n = 574 (%) | |
| Early neurological manifestations (ENM) | 326 (56.8) |
| Major neurological symptoms | 152 (26.5) |
| Encephalopathy | 143 (24.9) |
| Seizure | 5 (0.9) |
| Stroke | 7 (1.2) |
| Minor neurological symptoms | 174 (30.3) |
| Headache | 82 (14.3) |
| Myalgia | 80 (13.9) |
| Anosmia | 37 (6.5) |
| Dizziness or vertigo | 40 (7.0) |
| Dysgeusia | 43 (7.5) |
| Neurological manifestation while in hospital (NMD) | 129 (22.5) |
| Major in-hospital neurological complications | 58 (10.1) |
| Encephalopathy | 48 (8.4) |
| Seizure | 9 (1.6) |
| Ischemic stroke | 3 (0.5) |
| Critical illness myopathy/neuropathy | 5 (0.9) |
| Posterior reversible encephalopathy syndrome (PRES) | 2 (0.4) |
| Cerebral venous sinus thrombosis | 1 (0.2) |
| Minor in-hospital neurological complications | 80 (13.9) |
| Myalgia | 31 (5.4) |
| Headache | 30 (5.2) |
| Dizziness | 26 (4.5) |
| Dysgeusia | 22 (3.8) |
| Anosmia | 14 (2.4) |
| Acute neuropathic pain | 4 (0.7) |
| Ataxia | 1 (0.2) |
| Fatigue | 64 (11.2) |